glaucoma Archives -

Latest developments and innovations in ocular gene edit

New Horizon for Treatment of Inherited Retinal Dystrophy

https://pharmaphorum.com/events/new-horizon-for-treatment-of-inherited-retinal-dystrophy/

Partner Content/ Partner content/ Press releases

Queen’s University Belfast and Santen to Present Opening Keynote this November

Pavan Solanki gene editing, gene therapy, glaucoma, ophthalmology, santen 0 Comment

Ophthalmic Drugs Conference London

Queen’s University Belfast and Santen to Present Opening Keynote this November

https://pharmaphorum.com/partner-content/queens-university-belfast-and-santen-to-present-opening-keynote-this-november/

Market Access/ News/ News

Astellas buys eye gene therapy biotech Quethera for $109m

Piotr Wnuk Astellas, gene therapy, glaucoma, ocular disorders, ophthalmology, Quethera 0 Comment

Japanese Astellas Pharma has bought privately-owned biotech Quethera for $109 million, gaining access to its gene therapy focused

Astellas buys eye gene therapy biotech Quethera for $109m

https://pharmaphorum.com/news/astellas-expands-ocular-gene-therapy-investment/

Events/ Events/ R&D

Ophthalmic Drugs 2018

Pavan Solanki glaucoma, NHS, ophthalmic, ophthalmology, retina 0 Comment

Ophthalmic Drugs Conference 2018

Ophthalmic Drugs 2018

https://pharmaphorum.com/events/ophthalmic-drugs-2018/

Healthcare/ Partner content/ Press releases

SMi’s Europe’s Leading Ophthalmic Conference is only 3 weeks away!

Pavan Solanki glaucoma, lentivector, ophthalmic, preclinical, vision 0 Comment

Europe’s Leading Ophthalmic Conference

SMi’s Europe’s Leading Ophthalmic Conference is only 3 weeks away!

https://pharmaphorum.com/partner-content/smis-europes-leading-ophthalmic-conference-is-only-3-weeks-away/

Healthcare/ Partner content/ Press releases

Spotlight on Key Sessions at Ophthalmic Drugs this November

Pavan Solanki drugs, glaucoma, ophthalmic, ophthalmology, technologies

Sessions at Ophthalmic Drugs

Spotlight on Key Sessions at Ophthalmic Drugs this November

https://pharmaphorum.com/partner-content/spotlight-on-key-sessions-at-ophthalmic-drugs-this-november/

Events/ Events/ Healthcare

Ophthalmic Drugs – Europe’s Leading Ophthalmic Conference

Pavan Solanki glaucoma, nanotechnology, ophthalmology, optical, santen

Ophthalmic Drugs Conference

Ophthalmic Drugs – Europe’s Leading Ophthalmic Conference

https://pharmaphorum.com/events/ophthalmic-drugs-europes-leading-ophthalmic-conference/

Digital/ Healthcare/ Partner Content/ Partner content/ Press releases

Emerging & New Technologies in Drug Development

Pavan Solanki cataract, glaucoma, nanotechnology, ophthalmic, ophthalmology 0 Comment

Emerging & New Technologies in Drug Development

https://pharmaphorum.com/partner-content-digital/emerging-new-technologies-in-drug-development/

Digital/ Healthcare/ Partner Content/ Partner content/ Press releases

Spotlight on Key Sessions You Cannot Miss at Ophthalmic Drugs

Pavan Solanki Diabetic, DME, DMO, glaucoma, nanotechnology 0 Comment

Are you aware the ophthalmic market is expected to reach $21 billion by the year 2022? Ocular disease

Spotlight on Key Sessions You Cannot Miss at Ophthalmic Drugs

https://pharmaphorum.com/partner-content-digital/spotlight-on-key-sessions-you-cannot-miss-at-ophthalmic-drugs/

Trending

glaucoma

Login